Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment
FranceNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaAUR200 for Patients with Generalized Myasthenia Gravis
DenmarkDermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma
SpainGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
BulgariaLong-Term Study of Imeroprubart in Adults With Graves' Disease
BelgiumLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
BelgiumMesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission
SpainFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
AustriaTulisokibart for Psoriatic Arthritis in Adults
GermanyA study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
